Hebei Senlang Biotechnology Inc., Ltd.

This early-stage trial is testing a therapy called CD19 CAR-T cells for people with severe autoimmune diseases that haven't improved with standard treatments. It aims to see if this approach, which involves modifying a patient's own immune cells to target and remove harmful B cel…

This early-stage trial is testing a new personalized cell therapy called S103 for adults with multiple myeloma that has come back or stopped responding to standard treatments. Doctors will collect a patient's own immune cells, modify them to target the cancer, and infuse them bac…

This study is testing an experimental cell therapy called S101 for adults with a specific type of aggressive blood cancer (T-cell leukemia/lymphoma) that has come back or not responded to other treatments. Doctors will collect a patient's own immune cells, modify them in a lab to…